Burrill & Company

Entity type image
Type: Company
Name: Burrill & Company
First reported May 20 2013 - Updated May 20 2013 - 1 reports

Elan to buy AOP Orphan, Newbridge Pharmaceuticals

(M&A Navigator via COMTEX News Network) -- 20 May 2013 - Irish biotechnology company Elan Corporation plc (NYSE:ELN) said today that it had agreed to buy Austrian pharmaceutical firm AOP Orphan Pharmaceuticals AG and United Arab Emirates-based sector ... [Published PredictWallStreet - May 20 2013]
First reported May 15 2013 - Updated May 16 2013 - 1 reports

Gene-Based Diagnostics a Bright Spot in Life Sciences, Investor Says

Personalized medicine, or the examination of the genetic components of disease, is an area filled with promise but still somewhat lacking in terms of new treatments and medical products on the market. Nic Bothma/European Pressphoto Agency But some investors ... [Published WSJ.com: Venture Capital Dispatch - May 15 2013]
First reported May 02 2013 - Updated May 02 2013 - 1 reports

Navidea Biopharmaceuticals, Inc - Special Call

Navidea Biopharmaceuticals ( NAVB ) May 01, 2013 8:30 am ET Executives Brent L. Larson - Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary Mark Jerome Pykett - Chief Executive Officer, President ... [Published Healthcare Sector and Stocks Analysis from Seek ... - May 02 2013]
First reported May 01 2013 - Updated May 01 2013 - 2 reports
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc

Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers

http://media.marketwire.com/attachments/201107/29869_6151_burrill_logo_rgb.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1012627&ProfileId=051205&sourceType=1SAN FRANCISCO, CA -- (Marketwired) -- 05/01/13 -- Global M&A activity ... [Published I Stock Analyst - May 01 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports
University of California San Francisco
University of California San Francisco

Spiria Awarded Initial Funding from The Entrepreneurship Center at UCSF and Burrill & Company

Photo by Susan Merrell - Apr. 29, 2013 - SAN FRANCISCO -- Connie Cheung, B.S., and David Gorczyca, B.S., have teamed together to create Spiria, an exciting venture in . On April 8, 2013, Spiria received $15,000 from The Entrepreneurship Center at University ... [Published Prlog - Apr 29 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

The Burrill and Buck Aging Meeting, May 20th 2013

Here is a pointer to the website for a forthcoming conference to be held at the Buck Institute for Research on Aging in California. It is one of the many signs indicating that large, conservative financial entities like Burrill & Company are becoming ... [Published Fight Aging! - Apr 29 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 4 reports

Burrill Securities Launches Institutional Breakthrough Series

http://media.marketwire.com/attachments/201303/132959_Burrill_SecuritiesLLC_Logo.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011449&ProfileId=051205&sourceType=1NEW YORK, NY -- (Marketwired) -- 04/29/13 -- Gene therapy holds ... [Published I Stock Analyst - Apr 29 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Biomass Energy

San Francisco, CA Did you know olive pits have been used for over 15 years as a source of fuel in Turkey?Can a town get its energy from its own landfill biogas?Join us for a networking event and a fascinating panel discussion with experts to hear and ... [Published GreenBiz - Apr 22 2013]
First reported Apr 21 2013 - Updated Apr 21 2013 - 1 reports

SV 150: Health, biomedical industries jump in value

_ Silicon Valley's health and biomedical industries hired more people and enjoyed a 60 percent increase in market value last year while looking ahead to even more growth in 2013.With $21.7 billion in sales in 2012, the health and biomedical sectors as ... [Published Contra Costa Times - Apr 21 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Surprise! Surprise! Big Biotech's Outdo Big Pharma on Several Measures

As reported in Fierce Biotech, Burrill & Co did an analysis comparing biotechs to pharma over the past 3 years. Biotechs emerged as the winner on several key measures. Companies in the Big Pharma camp included J&J, Pfizer, Novartis, Merck, Roche, Sanofi, ... [Published The Big Red Biotech Blog - Apr 17 2013]
First reported Apr 16 2013 - Updated Apr 17 2013 - 2 reports

Biogen Idec, big biotechs trounce pharma players on multiple fronts this decade

This could be the decade of the big biotech companies, or Big Biotech. A new analysis shows that the biggest biotech players have outperformed a group of pharma giants over the previous three years, with the value of the biotech group up 57% compared ... [Published FierceBiotech - Apr 17 2013]
First reported Apr 15 2013 - Updated Apr 15 2013 - 2 reports

Life Sciences Leaders Launch Aging Conference Burrill & Buck Aging Meeting Will Consider the Challenge

SAN FRANCISCO, CA -- (Marketwired) -- 04/15/13 -- Graying populations and the growing burden placed by diseases of aging on healthcare systems around the world are creating a new urgency for the discovery and development of new treatments and cures. The ... [Published PR inside - Apr 15 2013]

Quotes

"AOP Orphan and Newbridge Pharmaceuticals together create a highly unique business platform. The geographic markets in which they operate are characterized by underlying growth and demand for health care products, broad economic development and increased patient and caregiver knowledge in disease areas such as oncology, cardiovascular-pulmonology, hematology, gastroenterology, neurology and a variety of rare and orphan diseases" said, Hans Peter Hasler, Elan's COO
Irish drugmaker Elan splurges $380 mn on two acquisitions [Published domain-b - May 20 2013]
...To wit they specially said "GnRH treatment (peripheral) reduced the magnitude of ageing histology in control mice" and "GnRH led to an amelioration of ageing-related cognitive decline."
Fight Aging! Newsletter, May 6th 2013 [Published Fight Aging! - May 05 2013]
...likely to change," says G Steven Burrill, CEO of Burrill & Company, a global financial services firm focused exclusively on the life sciences. "With Big Pharma companies rich with cash and needing to refill their pipelines, it's likely the pace of dealmaking will accelerate. Because much of that cash is outside of the United States, it could lead to more global acquisitions." M&A activity for the month could have been much bigger...
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Num ... [Published I Stock Analyst - May 01 2013]
...gene therapy approved in the western world, we are at an exciting time for this emerging sector," says Stephen Hurly, CEO of Burrill Securities. "We've seen waves of enthusiasm toward gene therapy surge and then quickly recede with high profile setbacks. This meeting will examine what's different now and why Big Pharma and Big Biotech have growing interests in the area."
Burrill Securities Launches Institutional Breakthrough Series [Published I Stock Analyst - Apr 29 2013]

More Content

All (67) | News (29) | Reports (9) | Blogs (15) | Audio/Video (0) | Fact Sheets (0) | Press Releases (14)
sort by: Date | Relevance
Irish drugmaker Elan splurges $380 mn on two ac... [Published domain-b - May 20 2013]
Elan to buy AOP Orphan, Newbridge Pharmaceuticals [Published PredictWallStreet - May 20 2013]
Gene-Based Diagnostics a Bright Spot in Life Sc... [Published WSJ.com: Venture Capital Dispatch - May 15 2013]
Cancer Genetics to Sponsor and Host Roundtable ... [Published Business Wire - May 14 2013]
Second Annual BioNJ Diagnostics & Personalized ... [Published Cafepharma - May 13 2013]
Fight Aging! Newsletter, May 6th 2013 [Published Fight Aging! - May 05 2013]
Navidea Biopharmaceuticals, Inc - Special Call [Published Healthcare Sector and Stocks Analysis from Seek ... - May 02 2013]
Thermo Fisher Scientific's $13.6 Billion Acquis... [Published I Stock Analyst - May 01 2013]
Thermo Fisher Scientific's $13.6 Billion Acquis... [Published NewsBlaze - May 01 2013]
Thermo Fisher Scientific's $13.6 Billion Acquis... [Published Marketwire - Breaking News Releases - May 01 2013]
Curis Management Discusses Q1 2013 Results - Ea... [Published Healthcare Sector and Stocks Analysis from Seek ... - May 01 2013]
Stifled by regulation, entrepreneurs take life-... [Published Venturebeat - Apr 30 2013]
Stifled by regulation, entrepreneurs take life-... [Published Venturebeat - Apr 30 2013]
Spiria Awarded Initial Funding from The Entrepr... [Published Prlog - Apr 29 2013]
Athersys to Present at Regen Med Investor Day 2... [Published Automotive Technology - Apr 29 2013]
The Burrill and Buck Aging Meeting, May 20th 2013 [Published Fight Aging! - Apr 29 2013]
Burrill Securities Launches Institutional Break... [Published I Stock Analyst - Apr 29 2013]
Burrill Securities Launches Institutional Break... [Published PR inside - Apr 29 2013]
Burrill Securities Launches Institutional Break... [Published FinanzNachrichten.de - Apr 29 2013]
Burrill Securities Launches Institutional Break... [Published Digital Journal - Apr 29 2013]
Two giants come to Digital Health Days: Steven ... [Published MyNewsDesk - Apr 25 2013]
State of the Biotech Industry: Burrill’s Biotec... [Published BioPortfolio - Apr 24 2013]
State of the Biotech Industry: Burrill’s Biotec... [Published I Am Biotech - Apr 24 2013]
Biomass Energy [Published GreenBiz - Apr 22 2013]
SV 150: Health, biomedical industries jump in v... [Published Contra Costa Times - Apr 21 2013]
Financings of the Fortnight Keeps Its Dauber Up [Published The IN VIVO Blog - Apr 18 2013]
Surprise! Surprise! Big Biotech's Outdo Big Pha... [Published The Big Red Biotech Blog - Apr 17 2013]
Biogen Idec, big biotechs trounce pharma player... [Published FierceBiotech - Apr 17 2013]
Big Biotech Outpaces Big Pharma, Burrill & Comp... [Published PR inside - Apr 16 2013]
Big Biotech Outpaces Big Pharma, Burrill & Comp... [Published Marketwire - Breaking News Releases - Apr 16 2013]
1 2 3
In Focus
  •  
Steven Burrill, Reni Benjamin, Edward Lanphier, [more]
  •  
Strand Life Sciences, Zoetis Inc, Thermo Fisher Scientific Inc, [more]
  •  
FDA Food & Drug Administration, National institutes of Health, Financial Industry Regulatory Authority, [more]
  •  
Life Science, Biotechnology, Big Pharma, [more]
  •  
Glybera, Zerenex, Truvada, [more]
  •  
San Francisco (United States), Bangalore, New York City, [more]
  •  
United States, India, Malaysia, [more]
  •  
Diseases, Narcotics, Epidemics, [more]
  •  
IT, Telecom, Utilities, [more]
Marketwire - Breaking News Releases, Financial Services, PR inside, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Gene-Based Diagnostics a Bright Spot in Life Sc... [Published WSJ.com: Venture Capital Dispatch - May 15 2013]
Personalized medicine, or the examination of the genetic components of disease, is an area filled with promise but still somewhat lacking in terms of new treatments and medical products on the market. Nic Bothma/European Pressphoto Agency But some investors ...
Fight Aging! Newsletter, May 6th 2013 [Published Fight Aging! - May 05 2013]
FIGHT AGING! NEWSLETTERMay 6th 2013 The Fight Aging! Newsletter is a weekly email containing news, opinions, and happenings for people interested in aging science and engineered longevity: making use of diet, lifestyle choices, technology, and proven ...
Stifled by regulation, entrepreneurs take life-... [Published Venturebeat - Apr 30 2013]
This story is part of a series exploring the themes of our upcoming health tech conference ,May 20-21 in San Francisco.Read the full series here .Chandra Duggirala, maker of an experimental device for type two diabetes, is on the verge of giving up.Duggirala’s ...
Stifled by regulation, entrepreneurs take life-... [Published Venturebeat - Apr 30 2013]
This story is part of a series exploring the themes of our upcoming health tech conference ,May 20-21 in San Francisco. Read the full series here . Chandra Duggirala, maker of an experimental device for type two diabetes, is on the verge ...
The Burrill and Buck Aging Meeting, May 20th 2013 [Published Fight Aging! - Apr 29 2013]
Here is a pointer to the website for a forthcoming conference to be held at the Buck Institute for Research on Aging in California. It is one of the many signs indicating that large, conservative financial entities like Burrill & Company are becoming ...
1 2 3

Press Releases

sort by: Date | Relevance
Cancer Genetics to Sponsor and Host Roundtable ... [Published Business Wire - May 14 2013]
Thermo Fisher Scientific's $13.6 Billion Acquis... [Published Marketwire - Breaking News Releases - May 01 2013]
Big Biotech Outpaces Big Pharma, Burrill & Comp... [Published Marketwire - Breaking News Releases - Apr 16 2013]
Advanced Cell Technology to Present at Regen Me... [Published Business Wire Health News - Apr 16 2013]
New Book Examines Biotech Industry in the Face ... [Published Marketwire - Breaking News Releases - Apr 02 2013]
1 2 3
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.